Morgan Stanley »

Reviva Pharmaceutcls Hldgs I shares owned by Morgan Stanley

Quarter-by-quarter ownership of Reviva Pharmaceutcls Hldgs I (RVPH) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Reviva Pharmaceutcls Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceutcls Hldgs I held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceutcls Hldgs I by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 5.6k 3.78
2023-09-30 $2.4k 501 4.88
2023-06-30 $4.4k 757 5.86
2022-12-31 $51 12 4.25

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Reviva Pharmaceutcls Hldgs I

Woodline Partners
Vanguard Group
Millennium Management
Schonfeld Strategic Advisors
Parkman Healthcare Partners
Susquehanna International
Geode Capital Management
Colony
Citadel Advisors
Polar Securities
EMC Capital Management
BlackRock
Northern Trust
Jpmorgan Chase & Co
Marshall Wace

View all funds holding Reviva Pharmaceutcls Hldgs I